Gabapentin
Product Images NDC 50090-5961

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-5961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
The text describes a chart showing the mean pain score on a 4-week dose titration period followed by a 4-week fixed dose period. The chart compares the pain score under a placebo condition versus a high dose of gabapentin (3600 mg/day) condition. There is a baseline score (not specified) included in the chart.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

FDA Label Image

Label Image (Lbl500905961)

Label Image (Lbl500905961)
Product No. 9817-0 is a medication called "ThansenTIN" in 300 mg capsules. The recommended storage temperature is at 810 7 degrees Celsius. There are 33 loose capsules in the package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.